Skip to content
value.today

Soar Health Inc.

🇺🇸 Denver, Colorado, USAHealth CareFounded 2020
Total raised
$55 M
4 rounds on record
Latest round
$17 M
Nov 2025
First round on record
Dec 2021
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Soar Health Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2025$17 MNo. 4$10 to $50 million

Soar Health Inc.: Raise no. 4, Nov 2025

Investors in this round

21 investors had bought by the notice of Dec 2, 2025: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,999,999 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ian Goldstein · Executive Officer, Director
  • Jennifer Goldstein · Executive Officer, Director
  • Bill Sullivan · Director
  • David Maughan · Director
  • Rafe Petty · Director
  • Varun Sawhney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The Company repurchased an aggregate of 387,684 shares of Common Stock from the Executive Officers for an aggregate amount of $1,999,999.74.”

Signed by Ian Goldstein, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 2, 2025. Read the notice at the SEC.

equitySEC
Aug 2024$19 MNo. 3$10 to $50 million

Soar Health Inc.: Raise no. 3, Aug 2024

Investors in this round

23 investors had bought by the notice of Aug 26, 2024: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $20 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ian Goldstein · Executive Officer, Director
  • Jennifer Goldstein · Executive Officer, Director
  • Bill Sullivan · Director
  • Rafe Petty · Director
  • Zach Gonzales · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ian Goldstein, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 26, 2024. Read the notice at the SEC.

equitySEC
Nov 2022$16 MNo. 2$10 to $50 million

Soar Health Inc.: Raise no. 2, Nov 2022

Investors in this round

19 investors had bought by the notice of Dec 13, 2022: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $17 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ian Goldstein · Executive Officer, Director, Promoter
  • Jennifer Goldstein · Executive Officer, Director, Promoter
  • Bill Sullivan · Director
  • Rafe Petty · Director
  • Zach Gonzales · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ian Goldstein, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 13, 2022. Read the notice at the SEC.

equitySEC
Dec 2021$2 MNo. 1$2 to $10 million

Soar Health Inc.: Raise no. 1, Dec 2021

Investors in this round

20 investors had bought by the notice of Dec 16, 2021: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$15,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ian Goldstein · Executive Officer, Director
  • Jennifer Goldstein · Executive Officer, Director
  • Rafe Petty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Asa C. Garber, Legal Counsel, McCarthy Garber Law, LLC. Source: SEC Form D, newest notice filed Dec 16, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Soar Health Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2025).

    SEC Form D · Dec 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2025

That is all the official record says: Soar Health Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Soar Health Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Soar Health Inc.
NameRoleNamed in
Ian GoldsteinExecutive officerDec 2025
Jennifer GoldsteinExecutive officerDec 2025
Bill SullivanDirectorDec 2025
David MaughanDirectorDec 2025
Ian GoldsteinDirectorDec 2025
Jennifer GoldsteinDirectorDec 2025
Rafe PettyDirectorDec 2025
Varun SawhneyDirectorDec 2025
Zach GonzalesDirectorAug 2024
Ian GoldsteinPromoterDec 2022
Jennifer GoldsteinPromoterDec 2022